Regenerative Medicine
8
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
PRP and PBD-VSEL Stem Cell Therapy for Parkinson's Disease
Comparative Study of Perinatal Tissues for Clinical-Grade Mesenchymal Stem Cell Production and Cost-Effectiveness
Regenerative Medicine Approach to Nasal Reconstruction
Efficacy of Platelet-rich Plasma in Improving Postoperative Scarring After Cesarean Delivery
MSCs for Prevention of MI-induced HF
MSC Infusion for Anti-aging and Regenerative Therapy
Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix
Dermal Micrografts in Regenerative Surgery